Immunotherapy and allogeneic stem cells transplantation

被引:0
|
作者
de Fontbrune, Flore Sicre [1 ]
Cavalieri, Doriane [2 ]
Leclerc, Mathieu [3 ]
Beckerich, Florence [3 ]
Maury, Sebastien [3 ]
de latour, Regis Peffault [1 ]
N-Guyen, Stephanie [4 ]
Bay, Jacques-Olivier [2 ]
机构
[1] GH Henri Mondor, Hematol Clin & Transplantat, Creteil, France
[2] CHU Clermont Ferrand, Serv Theapie Cellulaire & Hematol Clin Adulte, Site Estaing 1,Pl Lucie Aubrac, F-63000 Clermont Ferrand, France
[3] Hop St Louis, Serv Hematol Greffe Moelle, 1 Ave Claude Vellefaux, F-75475 Paris 10, France
[4] Univ Paris 06, Univ Sorbonne, AP HP,CNRS ERL8255,Serv Hematol Clin, Ctr Immunol & Malad Infect CIMI Paris,INSERM U113, Paris, France
关键词
HLA typing; Allogeneic transplantation; Immunotherapy; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSIONS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CORD BLOOD TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; MINOR HISTOCOMPATIBILITY ANTIGENS; DE-THERAPIE-CELLULAIRE; REDUCED-INTENSITY; T-CELLS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic stem cell transplantations represent perfect example of immunotherapy. Its positive aspects are due to the graft versus tumor effect. Unfortunately, this therapeutic advantage is usually associated with graft versus host effects. While the mechanism of these two graft reactions remain unclear, this is possible to modulate these immunologic effects. The type of conditioning regimen, the source of donor and the use of donor cells after the transplantation may influence the toxicity and the tumor response, leading to a better optimization of the procedure. This paper is presenting all the parameters which may contribute to improve allogeneic stem cell transplantations.
引用
收藏
页码:S164 / S174
页数:11
相关论文
共 50 条
  • [41] New immunotherapy-based approach in allogeneic hematopoietic stem cell transplantation
    Yoshinobu Maeda
    International Journal of Hematology, 2018, 107 : 129 - 129
  • [42] Leukemia immunotherapy in conjunction with non myeloablative allogeneic stem cell transplantation.
    Slavin, S
    Nagler, A
    Naparstek, E
    Or, R
    Varadi, G
    Ben-Yosef, R
    Hussien, A
    Aker, M
    Cividalli, G
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 779 - 779
  • [43] Effects of transplantation of facilitator cells on engraftment of allogeneic stem cells.
    El-Badri-Dajani, N
    Good, RA
    BLOOD, 1998, 92 (10) : 286B - 286B
  • [44] Generation of cytokine-induced killer cells for adoptive immunotherapy in rhabdomyosarcoma patients after allogeneic stem cell transplantation
    Voss, B.
    Kuci, S.
    Kreyenberg, H.
    Weber, G.
    Rettinger, E.
    Willasch, A.
    Klingebiel, T.
    Bader, P.
    KLINISCHE PADIATRIE, 2007, 219 (03): : 195 - 195
  • [45] Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
    Kuci, Selim
    Rettinger, Eva
    Voss, Bernhard
    Weber, Gerrit
    Stais, Miriam
    Kreyenberg, Hermann
    Willasch, Andre
    Kuci, Zyrafete
    Koscielniak, Ewa
    Kloess, Stephan
    von Laer, Dorothee
    Klingebiel, Thomas
    Bader, Peter
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1579 - 1586
  • [46] Mesenchymal Stem Cells as Cellular Immunotherapeutics in Allogeneic Hematopoietic Stem Cell Transplantation
    Papewalis, Claudia
    Topolar, Daniela
    Goetz, Barbara
    Schoenberger, Stefan
    Dilloo, Dagmar
    MESENCHYMAL STEM CELLS: BASICS AND CLINICAL APPLICATION II, 2013, 130 : 131 - 162
  • [47] TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS
    LINK, H
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 943 - 943
  • [48] Allogeneic mesenchymal stem cells transplantation in patients with refractory RA
    Jun Liang
    Xia Li
    Huayong Zhang
    Dandan Wang
    Xuebing Feng
    Hong Wang
    Bingzhu Hua
    Bujun Liu
    Lingyun Sun
    Clinical Rheumatology, 2012, 31 : 157 - 161
  • [49] Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine
    Strom, TB
    Field, LJ
    Ruediger, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3044 - 3049